These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20392343)

  • 1. Preventing the next generation of extensively drug-resistant tuberculosis.
    Ben Amor Y; Day MS; Schluger NW
    Int J Tuberc Lung Dis; 2010 May; 14(5):525-7. PubMed ID: 20392343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.
    Rosales S; Pineda-García L; Andino N; Almendarez N; Membreño H; Hoffner SE
    Int J Tuberc Lung Dis; 2009 Dec; 13(12):1542-9. PubMed ID: 19919774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First- and second-line drug resistance patterns among previously treated tuberculosis patients in India.
    Paramasivan CN; Rehman F; Wares F; Sundar Mohan N; Sundar S; Devi S; Narayanan PR
    Int J Tuberc Lung Dis; 2010 Feb; 14(2):243-6. PubMed ID: 20074419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensively drug-resistant tuberculosis: "there must be some kind of way out of here".
    Cegielski JP
    Clin Infect Dis; 2010 May; 50 Suppl 3():S195-200. PubMed ID: 20397948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensively drug-resistant (XDR) tuberculosis: an old and new threat.
    Fattorini L; Migliori GB; Cassone A
    Ann Ist Super Sanita; 2007; 43(4):317-9. PubMed ID: 18209265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-resistant tuberculosis: past, present, future.
    Chiang CY; Centis R; Migliori GB
    Respirology; 2010 Apr; 15(3):413-32. PubMed ID: 20337989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensively drug-resistant tuberculosis: current challenges and threats.
    Jain A; Mondal R
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensively drug-resistant tuberculosis in sub-Saharan Africa: an emerging public-health concern.
    Jones KD; Hesketh T; Yudkin J
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):219-24. PubMed ID: 18243260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Totally drug-resistant tuberculosis in India.
    Udwadia ZF; Amale RA; Ajbani KK; Rodrigues C
    Clin Infect Dis; 2012 Feb; 54(4):579-81. PubMed ID: 22190562
    [No Abstract]   [Full Text] [Related]  

  • 13. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
    Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
    Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of drug resistance in Mycobacterium tuberculosis.
    Zhang Y; Yew WW
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 16. XDR-TB in India : when will we heed the alarm?
    Udwadia ZF
    J Assoc Physicians India; 2008 Jun; 56():409-10. PubMed ID: 18822618
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis.
    Evans J; Segal H
    J Antimicrob Chemother; 2010 May; 65(5):897-900. PubMed ID: 20185419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis.
    Palomino JC; Martin A; Von Groll A; Portaels F
    J Microbiol Methods; 2008 Oct; 75(2):161-6. PubMed ID: 18627779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance.
    Kam KM; Sloutsky A; Yip CW; Bulled N; Seung KJ; Zignol M; Espinal M; Kim SJ
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):282-8. PubMed ID: 20132618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular tools for rapid identification and novel effective therapy against MDRTB/XDRTB infections.
    Viveiros M; Martins M; Couto I; Rodrigues L; Machado D; Portugal I; Amaral L
    Expert Rev Anti Infect Ther; 2010 Apr; 8(4):465-80. PubMed ID: 20377340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.